Biomanufacturing
Biomanufacturing is a type of manufacturing or biotechnology that utilizes biological systems to produce commercially important biomaterials and biomolecules for use in medicines, food and beverage processing, and industrial applications.
-
OCT 11, 2018 01:30 PM PDTC.E. CREDITS
OCT 11, 2018 01:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDTC.E. CREDITS
OCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDTC.E. CREDITS
OCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 09:00 AM PDTC.E. CREDITS
OCT 11, 2018 09:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 07:30 AM PDTC.E. CREDITS
OCT 11, 2018 07:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 06:00 AM PDTC.E. CREDITS
OCT 11, 2018 06:00 AM PDTPacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...Speaker: Jonas Korlach, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 12:00 PM PDTC.E. CREDITS
OCT 10, 2018 12:00 PM PDTRNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...Speaker: Jonathan Shaffer, MBA, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 10, 2018 12:00 PM PDTC.E. CREDITS
OCT 10, 2018 12:00 PM PDTTo date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...Speaker: Jerome Galon, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITS
OCT 10, 2018 09:00 AM PDTIn prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...Speaker: Paul Sondel, MD, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITS
OCT 10, 2018 09:00 AM PDTHigh-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...Speaker: Andrew Ravanelli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: MilliporeSigmaOCT 10, 2018 07:30 AM PDTC.E. CREDITS
OCT 10, 2018 07:30 AM PDTMolecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...Speaker: Karin Rodland, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 06:00 AM PDTC.E. CREDITS
OCT 10, 2018 06:00 AM PDTUnderstanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...Speaker: Samuel Rulli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENMAY 09, 2017 10:00 PM PDT
MAY 09, 2017 10:00 PM PDTThe CSIRO Tissue Culture Facility (CTCF) employs a range of in-house optimized platform technologies to identify optimum vector-host cell combinations for both transient and stable protein pr...Speaker: George Lovrecz, PhDPresented At:2017 Gibco ExpressionWorldAUG 20, 2014 07:15 AM PDT
AUG 20, 2014 07:15 AM PDTImagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of...Speaker: Michael C Jewett, PhDPresented At:Genetics and Genomics
OCT 11, 2018
01:30 PM PDT
C.E. CREDITS
OCT 11, 2018
01:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
C.E. CREDITS
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
C.E. CREDITS
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
09:00 AM PDT
C.E. CREDITS
OCT 11, 2018
09:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
07:30 AM PDT
C.E. CREDITS
OCT 11, 2018
07:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
06:00 AM PDT
C.E. CREDITS
OCT 11, 2018
06:00 AM PDT
PacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...
Speaker:
Jonas Korlach, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...
Speaker:
Jonathan Shaffer, MBA, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
To date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...
Speaker:
Jerome Galon, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
In prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...
Speaker:
Paul Sondel, MD, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
High-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...
Speaker:
Andrew Ravanelli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: MilliporeSigma
OCT 10, 2018
07:30 AM PDT
C.E. CREDITS
OCT 10, 2018
07:30 AM PDT
Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...
Speaker:
Karin Rodland, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
06:00 AM PDT
C.E. CREDITS
OCT 10, 2018
06:00 AM PDT
Understanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...
Speaker:
Samuel Rulli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
MAY 09, 2017
10:00 PM PDT
MAY 09, 2017
10:00 PM PDT
The CSIRO Tissue Culture Facility (CTCF) employs a range of in-house optimized platform technologies to identify optimum vector-host cell combinations for both transient and stable protein pr...
Speaker:
George Lovrecz, PhD
Presented At:2017 Gibco ExpressionWorld
AUG 20, 2014
07:15 AM PDT
AUG 20, 2014
07:15 AM PDT
Imagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of...
Speaker:
Michael C Jewett, PhD
Presented At:Genetics and Genomics
- Food & Beverage
- Neurotransmitters
- Anxiety
- Substances
- Animal and Veterinary Sciences
- ADME
- Cannabis Sciences
- Veterinary Sciences
- Food Science
- Biologics
- ALS
- Animal Behavior
- Animal Models
- Animal Sciences
- Lab Animals
- Marketing
- Laboratory Testing
- Neuroscience
- Industrial
- In-Vivo Research
- Point of Care
- Pharmaceuticals
- Therapeutics
